Allergy and Infectious Diseases Research federal obligations in Maryland

CFDA 93.855 meets Maryland place of performance

This tie keeps USAspending assistance rows where the CFDA number is 93.855 and the place of performance is Maryland. The dollar book is $2,135,445,735.07. The award count is 676. Those two facts describe a coding intersection. They do not prove that NIAID-style research clustered in Maryland because of a particular outbreak, a university ranking, or a campus square-footage total this packet does not contain.

CFDA 93.855 is the Allergy and Infectious Diseases Research assistance catalog line. Grants, cooperative agreements, and related assistance that carry that number can land on intramural campuses, extramural universities, and contractors whose performance state is coded MD. This packet does not split the 676 rows by recipient type, award instrument, or disease area. A vaccine-platform grant and a basic-immunology cooperative agreement can share the same statewide cell. Correlation is not causation.

NIH intramural employment, patent counts, and hospital-bed inventories are other series. They are not this award extract. A reader who treats $2,135,445,735.07 as Maryland’s full federal science budget has left the USAspending.gov CFDA-by-state definition. The 676 figure is a record count, including modifications present in the extract, not a count of laboratories or principal investigators.

Six hundred seventy-six awards on $2.14 billion

Six hundred seventy-six awards under $2,135,445,735.07 imply a mean near $3,158,943 per award. That quotient is blended. A few large multi-year cooperative agreements can pull the average up while many smaller R01-style actions sit below it. The packet has no median, no percentile, and no share of dollars on the largest ten awards.

Compared with formula-grant files that post a handful of statewide actions, 676 rows is a relatively thick tape for a single CFDA in one state. Volume and dollars are different columns. Cite both. USAspending.gov is the source; SpendingVault does not recast the mean as a typical NIAID grant size.

Maryland’s 93.855 cell is not the state total

Maryland’s state hub stacks every CFDA program with performance coded to the state. Allergy and Infectious Diseases Research is one program in that stack. $2,135,445,735.07 is not Maryland’s all-program obligation total. The nationwide CFDA 93.855 hub includes every state, so it is also not this cell.

Place-of-performance for a national research network can concentrate in one state even when subawards scatter. This packet does not reallocate subrecipients. Read the overlay as a coding view of 676 awards, not a map of Maryland’s biomedical workforce.

Commitments versus cash paid

The $2,135,445,735.07 figure is an obligation sum. Outlays on multi-year research vehicles can lag the obligation date by years. SpendingVault does not publish a 93.855-in-Maryland outlay total in this packet. Mixing citation counts or clinical-trial registries with this award file leaves the USAspending series.

Cite the join as CFDA 93.855 × Maryland, $2,135,445,735.07, 676 awards, obligations only.

Where the structured rows live

The Maryland × Allergy and Infectious Diseases Research overlay is the table view of the join. Recipient slices on that hub still sum toward $2,135,445,735.07 on 676 awards. The Maryland state page and the CFDA 93.855 program page are the parent rollups. Maryland’s programs index and the ties index list neighboring cells on the same obligation basis.

None of those links convert the cell into outlays or into disease-area shares this packet omits.

How to cite 93.855 in Maryland

Cite USAspending.gov: Allergy and Infectious Diseases Research (CFDA 93.855) obligated $2,135,445,735.07 on 676 awards coded to Maryland. Keep the obligation label. Keep both sides of the join. Do not report the cell as Maryland’s full federal total or as 93.855’s national book.

Later bulk files can revise both dollars and the 676-award count. This page is a packet snapshot. The overlay is the live table. The implied mean near $3,158,943 is a quotient of the two packet facts, not a typical project budget.

Questions

How much Allergy and Infectious Diseases Research spending is in Maryland?

USAspending.gov shows $2,135,445,735.07 in CFDA 93.855 obligations coded to Maryland across 676 awards. The join uses the program number and Maryland place of performance. The total is obligations, not outlays.

Is $2.14 billion Maryland’s full federal spending?

No. $2,135,445,735.07 is only the Allergy and Infectious Diseases Research cell. Other CFDA programs with Maryland place of performance sit on the statewide hub. CFDA 93.855 nationwide sits on the program page, which is not limited to Maryland.

What does 676 awards of CFDA 93.855 in Maryland include?

The extract counts 676 award records tagged to CFDA 93.855 and Maryland. Recipient-type and disease-area splits are not in this packet. The implied mean is about $3,158,943 per award from the two packet facts.

Do these obligations equal cash paid in Maryland?

No. $2,135,445,735.07 is an obligation sum. Outlays are a different USAspending series. Multi-year research vehicles can remain open after the obligation posts.